MoneyWorks4Me

Granules India informs about company updates

17 Oct 2016 Evaluate

Granules India has informed that Company’s Gagillapur facility located at Hyderabad, Telangana, India has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.15
Dr. Reddys Labs. 1190.20
Cipla 1374.60
Lupin 2087.65
Zydus Lifesciences 1154.80
View more..